Cerebrolysin
FPF-1070
A preparation of low molecular weight peptides and amino acids derived from porcine brain tissue, studied in stroke and dementia trials and the subject of a Cochrane review. Marketed in some countries; not FDA approved.
Tracking and educational reference only, on values you enter yourself. Not medical advice or a dosing recommendation.
Half-life
Not established in a public source, the product being a mixture rather than a single peptide. Half-life is an educational pharmacology figure, drawn from public sources, and is not a schedule or dosing instruction.
Storage & handling
No FDA-approved label defines handling.
References
- Cochrane Database of Systematic Reviews 2023: Cerebrolysin for acute ischaemic stroke
Read the source
Related in Cognitive / Longevity
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.